Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7UE9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,816
Award facts
- Contract value 100% obligated
- $37,816.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $37,816.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes on December 3, 2025, with completion scheduled for December 4, 2025. This non-set-aside contract represents a routine pharmaceutical procurement under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies pharmaceuticals across multiple therapeutic domains to military and veteran healthcare systems.
This delivery order is one of numerous competitive awards under AmerisourceBergen Drug Corp's comprehensive pharmaceutical support vehicle with the DLA, which enables the company to supply brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. The company holds a significant market position as a pharmaceutical prime vendor, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The award reflects AmerisourceBergen Drug Corp's demonstrated capability to meet federal procurement requirements through open competition and its role in supporting the military's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F7UE9?
SPE2DR26F7UE9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F7UE9 worth?
The government has obligated $37,816 on SPE2DR26F7UE9.
Is contract SPE2DR26F7UE9 an order under another contract?
Yes. SPE2DR26F7UE9 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UE9 competed?
The extent of competition for SPE2DR26F7UE9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award